Helicobacter pylori eradication in the healing of atrophic gastritis: A one-year prospective study

Scandinavian Journal of Gastroenterology

Volumn 41, Issue 7, 2006, Pages 782-790

  Arkkila, Perttu ^a   Seppälä, Kari ^a   Färkkilä, Martti ^a   Veijola, Lea ^b   Sipponen, Pentti ^c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b Malmi Hospital   (Finland)

^c JORVI HOSPITAL   (Finland)

Author keywords

Atrophic gastritis; H. pylori; Peptic ulcer

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; BISMUTH CITRATE; CLARITHROMYCIN; METRONIDAZOLE; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; RANITIDINE; TETRACYCLINE;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUODENUM ULCER; ERADICATION THERAPY; FEMALE; FINLAND; FOLLOW UP; GASTROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STOMACH ANTRUM; STOMACH ULCER; ULCER HEALING; WOUND HEALING;

AGED; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; FEMALE; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTESTINES; MALE; METAPLASIA; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 33745352915     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520500463175     Document Type: Article

References (36)

1. Fong TL, Dooley CP, Dehesa M, Cohen H, Carmel R, Fitzgibbons PL, et al. Helicobaaer pylori infection in pernicious anemia: a prospective controlled study. Gastroenterology 1991;100:328-32.
2. Karnes WE Jr, Samloff IM, Siurala M, Kekki M, Sipponen P, Kim SW, et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 1991;101:167-74.
3. Kuipers EJ, Uyterlinde AM, Pena AS, Roosendaal R, Pals G, Nelis GF, et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995;345:1525-8.
4. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney system. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161-81.
5. Sipponen P, Kekki M, Haapakoski J, Ihamaki T, Siurala M. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 1985;35:173-7.
6. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9.
7. Parsonnet J. Helicobacter pylori in the stomach: a paradox unmasked. N Engl J Med 1996;25;335:278-80.
8. Hansson LE, Nyren O, Hsing AW, Bergstrom R, Josefsson S, Chow WH, et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 1996;335:242-9.
9. Sipponen P. Long-term consequences of gastroduodenal inflammation. Eur J Gastroenterol Hepatol 1992;4:25-9.
10. Calmels S, Bereziat JC, Ohshima H, Bartsch H. Bacterial formation of N-nitroso compounds in the rat stomach after omeprazole-induced achlorhydria. IARC Sci Publ 1991;105:187-91.
11. Sobala GM, Schorah CJ, Sanderson M, Dixon MF, Tompkins DS, Godwin P, et al. Ascorbic acid in the human stomach. Gastroenterology 1989;97:357-63.
12. Bartsch H, Ohshima H, Pignatelli B. Inhibitors of endogenous nitrosation: mechanisms and implications in human cancer prevention. Mutat Res 1988;202:307-24.
13. Rood JC, Ruiz B, Fontham ET, Malcom GT, Hunter FM, Sobhan M, et al. Helicobacter pylori-associated gastritis and the ascorbic acid concentration in gastric juice. Nutr Cancer 1994;22:65-72.
14. Marshall BJ, Goodwin CS, Warren JR, Murray R, Blincow ED, Blackbourn SJ, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988;2:1437-42.
15. Seppälä K, Pikkarainen P, Sipponen P, Kivilaakso E, Gormsen MH. Cure of peptic gastric ulcer associated with eradication of Helicobacter pylori. Finnish Gastric Ulcer Study Group. Gut 1995;36:834-7.
16. Forbes GM, Warren JR, Glaser ME, Cullen DJ, Marshall BJ, Collins BJ. Long-term follow-up of gastric histology after Helicobacter pylori eradication. J Gastroenterol Hepatol 1996;11:670-3.
17. van der Hulst RW, van der Ende A, Dekker FW, Ten Kate FJ, Weel JF, Keller JJ, et al. Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study. Gastroenterology 1997;113:25-30.
18. Sung JJ, Lin SR, Ching JY, Zhou LY, To KF, Wang RT, et al. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology 2000;119:7-14.
19. Annibale B, Di Giulio E, Caruana P, Lahner E, Capurso G, Bordi C, et al. The long-term effects of cure of Helicobacter pylori infection on patients with atrophic body gastritis. Aliment Pharmacol Ther 2002;16:1723-31.
20. Kokkola A, Sipponen P, Rautelin H, Harkonen M, Kosunen TU, Haapiainen R, et al. The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia. Aliment Pharmacol Ther 2002;16:515-20.
21. Arkkila PE, Seppälä K, Kosunen TU, Haapiainen R, Kivilaakso E, Sipponen P, et al. Eradication of Helicobacter pylori improves the healing rate and reduces the relapse rate of nonbleeding ulcers in patients with bleeding peptic ulcer. Am J Gastroenterol 2003;98:2149-56.
22. Arkkila PE, Seppälä K, Kosunen TU, Sipponen P, Makinen J, Rautelin H, et al. Helicobacter pylori eradication as the sole treatment for gastric and duodenal ulcers. Eur J Gastroenterol Hepatol 2005;17:93-101.
23. Price AB. The Sydney system: histological division. J Gastroenterol Hepatol 1991;6:209-22.
24. Kosunen TU, Seppälä K, Sarna S, Sipponen P. Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet 1992;339:893-5.
25. Oksanen A, Veijola L, Sipponen P, Schauman KO, Rautelin H. Evaluation of Pyloriset Screen, a rapid whole-blood diagnostic test for Helicobacter pylori infection. J Clin Microbiol 1998;36:955-7.
26. Kolho K-L, Korhonen J, Verkasalo M, Lindahl H, Savilahti E, Rautelin H. Helicobacter pylori serology at diagnosis and follow-up of biopsy-verified infection in children. Scand J Infect Dis 2002;34:177-82.
27. Tucci A, Biasco G, Paparo GF. Effect of eradication of Helicobacter pylori in patients with fundic atrophic gastritis. N Engl J Med 1997;27;336:957-8.
28. Satoh K, Kimura K, Takimoto T, Kihira K. A follow-up study of atrophic gastritis and intestinal metaplasia after eradication of Helicobacter pylori. Helicobacter 1998;3:236-40.
29. Annibale B, Aprile MR, D'ambra G, Caruana P, Bordi C, Delle Fave G. Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL-cell hyperplasia. Aliment Pharmacol Ther 2000;14:625-34.
30. Ito M, Haruma K, Kamada T, Mihara M, Kim S, Kitadai Y, et al. Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis. Aliment Pharmacol Ther 2002;16:1449-56.
31. Yamada T, Miwa H, Fujino T, Hirai S, Yokoyama T, Sato N. Improvement of gastric atrophy after Helicobacter pylori eradication therapy. J Clin Gastroenterol 2003;36:405-10.
32. Oohara T, Tohma H, Aono G, Ukawa S, Kondo Y. Intestinal metaplasia of the regenerative epithelia in 549 gastric ulcers. Hum Pathol 1983;14:1066-71.
33. El-Omar EM, Oien K, El-Nujumi A, Gillen D, Wirz A, Dahill S, et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997;113:15-24.
34. Genta RM. Helicobacter pylori, inflammation, mucosal damage and apoptosis: pathogenesis and definition of gastric atrophy. Gastroenterology 1997;113:S51-5.
35. Moss SF, Calam J. Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobacter pylori. Gut 1993;34:888-92.
36. Dixon MF. Prospects for intervention in gastric carcinogenesis: reversibility of gastric atrophy and intestinal metaplasia. Gut 2001;49:2-4.